Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
| Current Price | ₹1,214.40 |
|---|---|
| Market Cap | ₹2,841 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 67.5 |
| Return on Equity | 5.53% |
| 52-Week Range | ₹886.00 – ₹1,610.00 |
| Beta (1Y) | 0.61 |
| Dividend Yield | 0.16% |
1. Specialty Chemicals-100%
Tatva Chintan Pharma Chem Ltd is trading at ₹1,214.40, with a market capitalisation of ₹2,841 Cr.
Tatva Chintan Pharma Chem Ltd operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Tatva Chintan Pharma Chem Ltd has a P/E of 67.5 and a return on equity of 5.53%.